Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
EPS Growth TrendStable
Percentile Rank100
3Y CAGR+25.6%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
+25.6%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2x
Strong expansion
Streak
2 yr
Consecutive growthStable
PeriodValue
202588.63%
20240.00%
2023-106.14%
202244.72%
202124.06%
2020-50.75%
201919.54%
2018-270.79%
2017-410.11%
20160.00%